Please login to the form below

Not currently logged in
Email:
Password:

Deloitte

This page shows the latest Deloitte news and features for those working in and with pharma, biotech and healthcare.

Pfizer appoints David Denton as chief financial officer and executive vice president

Pfizer appoints David Denton as chief financial officer and executive vice president

Denton has held various leadership roles, including senior vice president and controller/chief accounting officer and has previously worked with the management consulting firm of Deloitte Touche Tohmatsu.

Latest news

  • The forefront of technology innovation The forefront of technology innovation

    These are among Deloitte’s predictions for life sciences and the future for drugs companies and their operations, from The Future Awakens: Life Sciences and Health Care Predictions 2022 (Deloitte, November

  • Orphan drugs dominate FDA's record-breaking year Orphan drugs dominate FDA's record-breaking year

    A study published in December by Deloitte showed that R&D costs have doubled in eight years, while peak sales forecasts have halved.

  • Pharma’s R&D productivity sinks to a new low Pharma’s R&D productivity sinks to a new low

    The research by Deloitte’s Centre for Health Solutions found returns had declined 1.8 percentage points from 3.7% in 2017. ... Deloitte says the industry needs to tackle the problem with new ways of working and emphasis on finding the right talent.

  • Artificial intelligence in healthcare Artificial intelligence in healthcare

    According to a Deloitte report, AI ‘can help analyse large data sets from sources such as clinical trials, health records, genetic profiles and preclinical studies; within this data, it can recognise ... Deloitte also suggests AI can help improve study

  • NHS bracing for 'no deal’ Brexit impact, including medicines NHS bracing for 'no deal’ Brexit impact, including medicines

    According to a Deloitte survey, 75% of British companies are now pessimistic about Brexit after weak investment and waning revenues in the most recent financial quarter.

More from news
Approximately 2 fully matching, plus 18 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 8 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
The Difference Collective

Welcome to the Difference Collective – a healthcare communications team of 80+ talented experts who Deliver Differently. We’re purpose-built around...

Latest intelligence

Five big changes in the healthcare comms landscape
The world of healthcare has changed very greatly in the five years since The Difference Collective launched. Our agile model and talented team have enabled us to keep pace with...
Early communications in Pharma: How effective pre-approval comms delivers launch success
What communications are required for a successful launch...
Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....